Kiran Mazumdar-Shaw - Director, 10%+ Owner at Bicara Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
BCAX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kiran Mazumdar-Shaw since 4/22/2024

Holdings reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.44M $58.8M $13.24 Sep 16, 2024 By Biocon Limited
Common Stock 1.08M $14.3M $13.24 Sep 16, 2024 By Biocon Pharma Inc.
Common Stock 433K $5.73M $13.24 Sep 16, 2024 By Carica Investments
Common Stock 325K $4.3M $13.24 Sep 16, 2024 By Glentech International
Stock Option (Right to Buy) 23.7K Sep 12, 2024 Direct Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Limited Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Biocon Pharma Inc. Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Carica Investments Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 Sep 16, 2024 By Glentech International Common Stock

Transactions reported by Kiran Mazumdar-Shaw for Bicara Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.